Moderna Booster Shot
- All
- News
- Videos
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Moderna Says It Will Develop Booster Shot For New Covid Strain
The US pharmaceutical company Moderna said Friday it will develop a booster shot against the new Omicron variant of the coronavirus.
-
US Clears Covid Boosters For All Adults
The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday, as the world's hardest-hit country enters a new winter wave of the pandemic.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Must Vaccinate Those At Risk With Third Dose, Says Moderna Chief: Report
Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.
-
What You Need to Know About Moderna's New Vaccine For Omicron
Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Moderna Says It Will Develop Booster Shot For New Covid Strain
The US pharmaceutical company Moderna said Friday it will develop a booster shot against the new Omicron variant of the coronavirus.
-
US Clears Covid Boosters For All Adults
The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday, as the world's hardest-hit country enters a new winter wave of the pandemic.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Must Vaccinate Those At Risk With Third Dose, Says Moderna Chief: Report
Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.
